An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
Stefan Fernandez(Armed Forces Research Institute of Medical Science), Kenneth H. Eckels(Walter Reed Army Institute of Research), Lucile Warter, Stephen J. Thomas(Global Viral), J. Robert Putnak, Jean‐François Toussaint(Université Paris Cité), Pascale Festraets, Sally Mossman, Benoı̂t Baras, Bruce L. Innis(Universidad de Los Andes, Chile), Alexander Schmidt(ZHAW Zurich University of Applied Sciences), Richard G. Jarman(Walter Reed Army Institute of Research), Rafael De La Barrera(Walter Reed Army Institute of Research), Rawiwan Im‐Erbsin, Marie‐Pierre Malice
Cited by 60
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Proteome Organization in a Genome-Reduced Bacterium
|Science|2009|472
Rapid development of a DNA vaccine for Zika virus
|Science|2016|402
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
|New England Journal of Medicine|2015|390